BOCA RATON, Fla., July 24, 2026 /OrthoSpineNews/ – SurGenTec®, a medical device company focused on advancing treatment options for orthopedic and spine surgery, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its ION-L™ navigation instruments for use with the ION-L™ Lumbar Facet Fixation System. The system is engineered for compatibility with Medtronic’s StealthStation™ navigation platform, enabling enhanced precision during posterior lumbar facet fusion procedures.
SurGenTec® Secures FDA Clearance for ION-L™ – Lumbar Navigation Compatible
2 min read Premium comments
fixationinstrumentsSurGenTecfusionfacetlumbar navigation
Designed to support enhanced procedural accuracy and engineered for compatibility with navigation, the ION-L™ navigation instruments are intended to assist surgeons in precisely locating anatomical structures, specifically the lumbar facet joint, during open or minimally invasive spinal procedures to support implant placement and surgical workflow efficiency.
ION-L™ was engineered with a zero-profile implant design and controlled drill-to-implant geometry to support controlled, non-impact placement and implant depth accuracy. The system was developed to help maintain the facet joint in a neutral position while reducing the risk of unintended joint expansion during insertion, supporting controlled posterior lumbar fixation while helping preserve native spinal alignment.
Key potential benefits of navigated ION-L™ facet fixation include:
Precision placement during lumbar facet targeting
Improved visualization of lumbar anatomy and surrounding structures
Increased procedural control and surgical confidence
Potential reductions in operative time, radiation exposure, and procedural complications
As navigation-assisted spine procedures continue to evolve, the ION-L™ navigation instruments represent another step forward in precision-driven lumbar spine technology.
Travis Greenhalgh, CEO and Founder of SurGenTec®, stated:
“Navigation compatibility for ION-L™ demonstrates our continued commitment to giving surgeons advanced options as they treat patients with lumbar spine disease requiring fixation. For years, achieving precision during posterior lumbar fixation has depended heavily on fluoroscopic guidance and surgeon experience alone. With ION-L™ now compatible with navigation, surgeons have another tool to support accurate, efficient placement while continuing to benefit from a less invasive approach.”
About SurGenTec®
SurGenTec® is a privately held medical device company dedicated to advancing spine and orthopedic surgery through innovative, minimally invasive technologies. Focused on improving clinical outcomes and addressing unmet needs in posterior lumbar fixation, the company offers a comprehensive portfolio that includes facet fixation technologies, a synthetic biologics portfolio, bone marrow aspiration kits, and sacroiliac joint fixation systems. SurGenTec® is committed to driving growth and supporting global surgical innovation, with recent expansion into international markets, including its international sales headquarters in Brazil.
Contacts
SurGenTec® Customer Service
(561) 990-7882
customerservice@surgentec.com
Author
TH
TJ Halvorson
The De Angelis Group | Orthopedics This Week | MSK Innovations
Why This Matters
Two Perspectives
MBA Lens: Economic and industry impact
SurGenTec® secured FDA clearance for its ION-L™ navigation instruments, enhancing its Lumbar Facet Fixation System. This strategic move leverages the growing trend in navigation-assisted spine procedures by ensuring compatibility with Medtronic’s StealthStation™. The clearance positions SurGenTec to improve surgical efficiency, potentially reduce operative time and radiation exposure, and support broader adoption in the lumbar fixation market, aligning with the company's international growth strategy.
- The FDA clearance for ION-L™ navigation instruments, compatible with Medtronic's StealthStation™, enhances SurGenTec's market position in precision lumbar facet fusion.
- This development aims to drive adoption by offering improved procedural control, efficiency, and potential reductions in operative time and radiation exposure.
PhD Lens: Clinical and outcomes impact
SurGenTec®'s ION-L™ navigation instruments received FDA clearance for use with its Lumbar Facet Fixation System, designed for enhanced precision in posterior lumbar facet fusion. The system features a zero-profile implant and controlled drill-to-implant geometry, facilitating non-impact placement and depth accuracy. Compatibility with navigation platforms aims to improve visualization, support precise anatomical targeting, and help maintain the facet joint in a neutral position, preserving native spinal alignment.
- The ION-L™ system utilizes a zero-profile implant design and controlled drill-to-implant geometry for precise, non-impact placement and depth accuracy.
- Navigation compatibility enhances visualization and anatomical targeting, aiming to preserve native spinal alignment and reduce procedural complications.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.